Advertisement
Advertisement
VERU
Veru Inc.
2.35
USDSponsored
+0.10
+4.69%
Feb 06, 15:57 UTC -5
Closed
After-Market
2.38
+0.03
+1.28%
VERU Earnings Reports
Positive Surprise Ratio
VERU beat 18 of 34 last estimates.
53%
Next Report
In 3 Days
Date of Next Report
Feb 11, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/-$0.47
Implied change from Q4 25 (Revenue/ EPS)
--
/-570.00%
Implied change from Q1 25 (Revenue/ EPS)
--
/-21.67%
Veru Inc. earnings per share and revenue
On Dec 17, 2025, VERU reported earnings of 0.10 USD per share (EPS) for Q4 25, beating the estimate of -0.43 USD, resulting in a 123.07% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -8.61% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.47 USD, with revenue projected to reach -- USD, implying an decrease of -570.00% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
Boston Scientific Corp.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.78
Actual
$0.80
Surprise
+1.61%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
GE HealthCare Technologies Inc. Common Stock
Report Date
Feb 04, 2026 For Q4 25
Estimate
$1.42
Actual
$1.44
Surprise
+0.96%
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.32
Actual
$0.38
Surprise
+15.43%
Prestige Consumer Healthcare Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.15
Actual
$1.13
Surprise
-1.36%
Haemonetics Corporation
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.26
Actual
$1.31
Surprise
+3.75%
Phibro Animal Health Corporation Class A
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.68
Actual
$0.87
Surprise
+27.30%
Canopy Growth Corporation Common Shares
Report Date
Feb 06, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.13
Surprise
-198.00%
Aurora Cannabis Inc. Common Shares
Report Date
Feb 04, 2026 For Q3 26
Estimate
$0.21
Actual
$0.12
Surprise
-42.72%
FAQ
What were Veru Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Veru Inc. reported EPS of $0.10, beating estimates by 123.07%, and revenue of $0.00, 0% as expectations.
How did the market react to Veru Inc.'s Q4 2025 earnings?
The stock price moved down -8.61%, changed from $2.44 before the earnings release to $2.23 the day after.
When is Veru Inc. expected to report next?
The next earning report is scheduled for Feb 11, 2026.
What are the forecasts for Veru Inc.'s next earnings report?
Based on 4
analysts, Veru Inc. is expected to report EPS of -$0.47 and revenue of -- for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement